CTSB and cancer: As a result, theranostic agent 8 only produced NIR fluorescence imaging and PDT therapy in cancer cells that were FR-positive and overexpressing cathepsin B. Additionally, this dual-targeted approach boosted the tumour suppression impact, decreased unwanted phototoxic effects, and raised the target-to-background ratio in in vivo imaging.